Incidence of Treatment-Emergent Adverse Events in Parkinson's Disease Patients According to Baseline Mao-B Inhibitors Use: Post-Hoc Analysis from Double-Blind Combined Bipark-I and Ii Data
AuthID
P-00R-WD9
P-00R-WD9